NISO Member News
London, UK | December 4, 2023
Knowledge services provider Taylor & Francis has today announced the addition of Future Science Group (FSG), publisher of medical, biotechnological and scientific research. As well as bringing a portfolio of cutting-edge journals and digital hubs, FSG’s leading publishing solutions program will enable Taylor & Francis to offer researchers and medical communication planners a host of additional services.
Taylor & Francis now becomes the fourth largest publisher of pharma-funded research, with the addition of 32 peer-reviewed FSG journals and five digital hubs. These complement the existing range of over 340 Taylor & Francis medical and healthcare journals, including the Expert Collection, which is the world’s largest series of review journals in research, development and clinical medicine.
FSG publications represent many of the most important and fast-growing fields of scientific, medical and pharmaceutical research, including oncology, medicinal chemistry, immunotherapy, microbiology, nanomedicine and biotechnology. Researchers can choose to publish open access (OA) in all FSG journals, with 15 titles fully OA.
The addition of FSG will also accelerate the growth of Taylor & Francis services for researchers and medical communication planners. FSG’s market-leading Plain Language Summary Hub supports authors to make technical content accessible for lay audiences and empowers patients in decision-making about their care.
Leon Heward-Mills, Researcher Services Managing Director at Taylor & Francis, said: “We’ve long respected the work of FSG’s creative and plain-language summary teams. Their expertise will help us scale up our existing researcher services programs, deepen our relationships with customers, and support real-world impact.”
James Drake, Founder and Chairman of Future Science Group, said: “Over the last 22 years, FSG has developed a range of unique offerings, all underpinned by a mission to convene scientific communities, and support translation, collaboration and innovation. These are priorities I know the team at Taylor & Francis value too. I’m certain that the move we’re announcing today will ensure the FSG journals, hubs and services reach their full potential and continue to meet the evolving needs of today’s researchers.”
Liz Knowles, Global Portfolio Director for Medicine at Taylor & Francis added, “The FSG journals and hubs are a perfect fit for Taylor & Francis, complementing our existing areas of strength as well as supporting growth in many of the fields we had identified for extra investment. We’re looking forward to working with our new colleagues to increase the reach and impact of FSG publications with research communities across the globe.”
About These Organizations
About Future Science Group
Founded in 2001, Future Science Group is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG’s portfolio consists of three publishing imprints, Future Science, Future Medicine and Newlands Press. In addition to a core business of subscription and open access journal publishing, FSG develops specialist digital hubs, such as Bioanalysis Zone, enabling professionals to easily connect and collaborate with their peers in niche scientific fields.
About Taylor & Francis
Taylor & Francis supports diverse communities of experts, researchers and knowledge makers around the world to accelerate and maximize the impact of their work. We are a leader in our field, publish across all disciplines and have one of the largest Humanities and Social Sciences portfolios. Our expertise, built on an academic publishing heritage of over 200 years, advances trusted knowledge that fosters human progress.
Our 2,500+ people, based in a global network of offices in more than 15 countries, use their skills and the latest technology to curate, validate and share impactful advanced, emergent and applied knowledge. Under the Taylor & Francis, Routledge and F1000 imprints we publish 2,700 journals, 8,000 new books each year and partner with more than 700 scholarly societies.
Taylor & Francis is proud to be a Global Certified Accessible™ publisher and our operations and all our print publications are certified CarbonNeutral®.